In Memory of Inmaculada "Imma" Mercado
On August 9, 2020 I received the devestating news that my staff member Imma Mercado had passed away. Imma was more than an employee to me, she was a dear friend and one who I shared many laughs and tears with. On December 31, 2019 Imma FaceTimed me to tell me that her stomach ache had been diagnosed as colon cancer. Later we found out it was stage four. I promised Imma that I would be there with her evry step of the way and I glad to say I was.
With that said, I'm raising money for critical cancer research at Memorial Sloan Kettering—where new discoveries are revolutionizing how cancer is diagnosed and treated. Join me in making a difference by donating today!
I am also raising money to post Imma's name on the MSK digital wall at main campus. Imma loved her job and worked hard for the patients here at MSK and I think this would be a wonderful way to keep her spirit here in the halls of MSK.
Donors Fuel Progress
When you give to MSK, you're making a direct impact: from innovative research that can move newly discovered drugs into clinical trials, to the cancer treatment and care patients receive every day.
Fundraising efforts can lead to important and life-changing breakthroughs in cancer research—making it possible for scientists to overcome the hurdles of funding gaps. Philanthropy provides the tools they need to swiftly pursue promising research initiatives.
MSK Leads Cancer Care
Your gift supports the best and brightest researchers in their work to outsmart cancer. These innovative thinkers are focused on fighting every form of the disease. The close collaboration between MSK's doctors and researchers is unique and one of its greatest strengths—ensuring that drugs and therapies developed in the lab can be moved quickly to the clinic.
Together, we can join the leaders in cancer research by funding a future with better outcomes for people with cancer and their families—not just at MSK, but around the world.
Every dollar brings more hope. Thank you!
If you think this page contains objectionable content, please inform the system administrator.